The new development bank issued 7 billion yuan of Panda Bonds for infrastructure projects in member countries
On the 18th, the BRICs New Development Bank successfully issued a panda bond in China's inter-bank bond market. The bond scale is 7 billion yuan, the term is three years, and the coupon rate is 2.70%. The raised funds will be used for general purposes in China, and will provide financing for infrastructure and sustainable development projects in member countries.
This text is a result of machine translation.
Related companies：
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Immunotherapy is emerging as a powerful weapon in fighting cancer by restarting and maintaining the cancer-immunity cycle to identify, control and eliminate tumor cells rather than killing them directly.
Nov 24, 2022 06:29 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 26, 2022 12:26 PM
Briefing Feb 20, 2022 03:49 PM
· Healthcare
A fire broke out in a mechanical and electrical plant in Huaiyuan, Anhui Province, and local fire and public security departments are rescuing
Briefing Jan 31, 2022 10:29 AM
· Healthcare
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
Insight
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Following the digital therapeutics series report, this article is centered on the challenges and opportunities faced by the digital therapeutics industry and aims to provide insights on the two above aspects.
Nov 23, 2022 03:23 PM
Briefing Jan 14, 2022 02:18 PM
· Healthcare
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
Healthcare
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
See more
Read next
Insight
In-depth
Insight
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Nov 24, 2022 06:29 PM
Insight
In-depth
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Nov 23, 2022 03:23 PM
Insight
In-depth